Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment. (2019)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.cell.2018.12.038
PubMed Identifier: 30712866
Publication URI: http://europepmc.org/abstract/MED/30712866
Type: Journal Article/Review
Volume: 176
Parent Publication: Cell
Issue: 4
ISSN: 0092-8674